Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus

American Journal of Pathology

Volumn 166, Issue 3, 2005, Pages 801-809

  Kim, Taeg S ^a   Perlman, Stanley ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; COMPLEMENT RECEPTOR; FC RECEPTOR; RAG1 PROTEIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CORONAVIRUS; DEMYELINATION; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 14644439925     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62301-2     Document Type: Article

References (54)

1. Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002, 3:291-301
2. Noseworthy JH: Progress in determining the causes and treatment of multiple sclerosis. Nature 1999, 399:A40-A47
3. Steinman L: Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999, 24:511-514
4. Wu GF, Dandekar AA, Pewe L, Perlman S: CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000, 165:2278-2286
5. Wang F, Stohlman SA, Fleming JO: Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 1990, 30:31-41
6. Houtman JJ, Fleming JO: Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 1996, 2:101-110
7. Wu GF, Perlman S: Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999, 73:8771-8780
8. Haring JS, Pewe LL, Perlman S: Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J Immunol 2002, 169:1550-1555
9. Archelos JJ, Storch MK, Hartung HP: The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000, 47:694-706
10. Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, Gilden DH: Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 2003, 171:2725-2733
11. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A: Multiple sclerosis and Epstein-Barr virus. JAMA 2003, 289:1533-1536
12. Burgoon MP, Hammack BN, Owens GP, Maybach AL, Eikelenboom MJ, Gilden DH: Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 2003, 54:459-463
13. Raine CS, Cannella B, Hauser SL, Genain CP: Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999, 46:144-160
14. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938-952
15. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H. Mayringer I, Dilitz E, Deisenhammer F. Reindl M: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003, 349:139-145
16. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717
17. Wekerle H: Remembering MOG: autoantibody mediated demyelination in multiple sclerosis? Nat Med 1999, 5:153-154
18. Genain CP, Cannella B, Hauser SL, Raine CS: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999, 5:170-175
19. Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DA: The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 1989, 112:895-911
20. Nataf S, Carroll SL, Wetsel RA, Szalai AJ, Barnum SR: Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol 2000, 165:5867-5873
21. Calida DM, Constantinescu C, Purev E, Zhang GX, Ventura ES, Lavi E, Rostami A: Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendracyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J Immunol 2001, 166:723-726
22. Tran GT, Hodgkinson SJ, Carter N, Killingsworth M, Spicer ST, Hall BM: Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords. J Immunol 2002, 168:4293-4300
23. Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP: The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 2002, 168:458-465
24. Abdul-Majid KB, Stefferl A, Bourquin C, Lassmann H, Linington C, Olsson T, Kleinau S, Harris RA: Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol 2002, 55: 70-81
25. Song WC, Sarrias MR, Lambris JD: Complement and innate immunity, Immunopharmacology 2000, 49:187-198
26. Kim AH, Dimitriou ID, Holland MC, Mastellos D, Mueller YM, Altman JD, Lambris JD, Katsikis PD: Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 2004, 173:2524-2529
27. Perlman S, Schelper R, Bolger E, Ries D: Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microbiol Pathog 1987, 2:185-194
28. Collins AR, Knobler RL, Powell H, Buchmeier MJ: Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 1982, 119:358-371
29. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL: Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 1984, 132:261-270
30. Stohlman SA, Hinton DR: Viral induced demyelination. Brain Pathol 2001, 11:92-106
31. Dandekar AA, Perlman S: Virus-induced demyelination in nude mice is mediated by gamma delta T cells. Am J Pathol 2002, 161:1255-1263
32. Kyuwa S, Cohen M, Nelson G, Tahara SM, Stohlman SA: Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis. J Virol 1994, 68:6815-6819
33. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA: Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989, 168:162-167
34. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM: FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 2002, 16:379-389
35. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D: Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168
36. Baumann U, Kohl J, Tschernig T, Schwerter-Strumpf K, Verbeek JS, Schmidt RE, Gessner JE: A codominant role of Fc gamma RI/III and CSaR in the reverse Arthus reaction. J Immunol 2000, 164:1065-1070
37. Vriesendorp FJ, Flynn RE, Malone MR, Pappolla MA: Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis. Acta Neuropathol (Berl) 1998, 95:297-301
38. Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA: Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 2004, 78:1739-1750
39. Matthews AE, Lavi E, Weiss SR, Paterson Y: Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J Neurovirol 2002, 8:257-264
40. Mahad DJ, Ransohoff RM: The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 2003, 15:23-32
41. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713-726
42. Youssef S, Wildbaum G, Maor G, Lanir N, Gour-Lavie A, Grabie N, Karin N: Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J Immunol 1998, 161:3870-3879
43. Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE: Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 2004, 172:4018-4025
44. Chen BP, Kuziel WA, Lane TE: Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001, 167:4585-4592
45. Pewe L, Haring J, Perlman S: CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus. J Virol 2002, 76:7329-7333
46. Pewe LL, Perlman S: CD8 T cell-mediated demyelination is IFN-γ dependent in mice infected with a neurotropic coronavirus. J Immunol 2002, 168:1547-1551
47. Tran EH, Hoesktra K, van Rooijen N, Dijkstra CD, Owens T: Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998, 161:3767-3775
48. Smith ME: Phagocytosis of myelin in demyelinative disease: a review. Neurochem Res 1999, 24:261-268
49. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD: Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 1996, 70:145-152
50. Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE: C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 2002, 110:1823-1830
51. Speth C, Dierich MP, Gasque P: Neuroinvasion by pathogens: a key role of the complement system. Mol Immunol 2002, 38:669-679
52. Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001, 19:275-290
53. Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580-592
54. Gay FW, Drye TJ, Dick GW, Esiri MM: The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997, 120:1461-1483